Ratings by Jefferies (Akash Tewari)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/2/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2025 | Enanta Pharmaceuticals | ENTA | Upgrade | Buy (Hold) |
11.97 (13.54) |
13.12% | Details | |
| 9/22/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2025 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Crescent Biopharma Inc | CBIO | New Coverage | Buy (N/A) |
14.40 (12.07) |
-16.18% | Details | |
| 8/19/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Jade Biosciences | JBIO | New Coverage | Buy (N/A) |
9.82 (14.05) |
43.08% | Details | |
| 7/8/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2025 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2025 | Arvinas Inc. | ARVN | Downgrade | Hold (Buy) |
9.62 (13.60) |
41.37% | Details | |
| 4/23/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Hold (N/A) |
|
Details | ||
| 1/27/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2025 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2025 | Third Harmonic Bio | THRD | Maintain | Hold (N/A) |
|
Details | ||
| 1/13/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Bristol-Myers Squibb Co. | BMY | Upgrade | Buy (Hold) |
55.78 (60.29) |
8.09% | Details | |
| 12/16/2024 | Bristol-Myers Squibb Co. | bmy | Upgrade | Buy (Hold) |
55.78 (55.78) |
0% | Details | |
| 11/22/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2024 | BioNTech | BNTX | Upgrade | Buy (Hold) |
123.40 (101.50) |
-17.75% | Details | |
| 9/13/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
| 9/10/2024 | Relay Therapeutics | RLAY | Upgrade | Buy (Hold) |
6.24 (9.89) |
58.49% | Details | |
| 9/9/2024 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 8/22/2024 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2024 | Ionis Pharmaceuticals | IONS | Upgrade | Buy (Underperform) |
47.57 (74.04) |
55.64% | Details | |
| 6/18/2024 | Zentalis Pharmaceuticals | ZNTL | Downgrade | Hold (Buy) |
8.39 (2.30) |
-72.59% | Details | |
| 6/10/2024 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2024 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2024 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/23/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2024 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2024 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2024 | Apellis Pharmaceuticals | APLS | Upgrade | Buy (Hold) |
62.13 (20.07) |
-67.7% | Details | |
| 2/1/2024 | Merck | MRK | Maintain | Buy (Buy) |
|
Details | ||
| 1/26/2024 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2024 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2024 | Relay Therapeutics | RLAY | Maintain | Hold (N/A) |
|
Details | ||
| 1/18/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2023 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Spyre | SYRE | New Coverage | Buy (N/A) |
19.86 (40.15) |
102.17% | Details | |
| 12/6/2023 | Arvinas Inc. | ARVN | Upgrade | Buy (Hold) |
23.17 (9.62) |
-58.48% | Details | |
| 11/29/2023 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Acelyrin Inc | SLRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Pfizer | PFE | Upgrade | Buy (Hold) |
32.92 (27.05) |
-17.83% | Details | |
| 10/9/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Eli Lilly | LLY | Upgrade | Buy (Hold) |
454.08 (990.33) |
118.1% | Details | |
| 8/8/2023 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
20.70 (73.05) |
252.9% | Details | |
| 8/8/2023 | Enanta Pharmaceuticals | ENTA | Downgrade | Hold (Buy) |
19.82 (11.97) |
-39.61% | Details | |
| 8/2/2023 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 7/21/2023 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 7/17/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2023 | Pfizer | PFE | Maintain | Hold (N/A) |
|
Details | ||
| 6/22/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Terns Pharmaceuticals | TERN | New Coverage | Buy (N/A) |
12.20 (42.82) |
250.98% | Details | |
| 5/30/2023 | Acelyrin Inc | SLRN | New Coverage | Buy (N/A) |
19.27 (2.27) |
-88.22% | Details | |
| 5/19/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2023 | Eli Lilly | LLY | Maintain | Hold (N/A) |
|
Details | ||
| 4/27/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2023 | Relay Therapeutics | RLAY | Upgrade | Hold (Underperform) |
11.62 (6.24) |
-46.3% | Details | |
| 4/6/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
751.30 (759.86) |
1.14% | Details | |
| 3/6/2023 | Eli Lilly | LLY | New Coverage | Hold (N/A) |
315.05 (990.33) |
214.34% | Details | |
| 3/6/2023 | Pfizer | PFE | New Coverage | Hold (N/A) |
40.62 (27.05) |
-33.41% | Details | |
| 3/6/2023 | Merck | MRK | New Coverage | Buy (N/A) |
107.01 (115.79) |
8.2% | Details | |
| 3/6/2023 | Bristol-Myers Squibb Co. | BMY | New Coverage | Hold (N/A) |
69.19 (55.78) |
-19.38% | Details | |
| 2/7/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2022 | Third Harmonic Bio | THRD | Downgrade | Hold (Buy) |
19.80 (5.38) |
-72.83% | Details | |
| 12/12/2022 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
12.50 (1.55) |
-87.6% | Details | |
| 11/29/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2022 | Third Harmonic Bio | THRD | New Coverage | Buy (N/A) |
20.01 (5.38) |
-73.11% | Details | |
| 9/9/2022 | Regeneron Pharma | REGN | Upgrade | Hold (Underperform) |
596.44 (759.86) |
27.4% | Details | |
| 9/7/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Downgrade | Hold (Buy) |
63.84 (68.49) |
7.28% | Details | |
| 6/21/2022 | Arvinas Inc. | ARVN | New Coverage | Hold (N/A) |
36.79 (13.60) |
-63.03% | Details | |
| 6/6/2022 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
94.42 (128.13) |
35.7% | Details | |
| 6/6/2022 | Relay Therapeutics | RLAY | New Coverage | (N/A) |
16.78 (9.89) |
-41.06% | Details | |
| 6/6/2022 | Regeneron Pharma | REGN | New Coverage | Underperform (N/A) |
630.70 (759.86) |
20.48% | Details | |
| 5/19/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2022 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2022 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2021 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
68.59 (8.39) |
-87.77% | Details | |
| 10/7/2021 | argenx SE | ARGX | New Coverage | Buy (N/A) |
294.06 (717.80) |
144.1% | Details | |
| 10/7/2021 | Madrigal Pharmaceuticals | MDGL | New Coverage | Buy (N/A) |
78.62 (432.83) |
450.53% | Details | |
| 10/7/2021 | Alkermes | ALKS | New Coverage | Hold (N/A) |
30.88 (28.63) |
-7.29% | Details | |
| 10/7/2021 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
36.81 (60.41) |
64.11% | Details | |
| 10/7/2021 | Acceleron Pharma | XLRN | New Coverage | Hold (N/A) |
177.13 (178.75) |
0.91% | Details | |
| 10/7/2021 | BioNTech | BNTX | New Coverage | Hold (N/A) |
250.12 (123.40) |
-50.66% | Details | |
| 10/7/2021 | Enanta Pharmaceuticals | ENTA | New Coverage | Buy (N/A) |
60.52 (13.54) |
-77.63% | Details | |
| 10/6/2021 | Global Blood Therapeutics | GBT | New Coverage | Buy (N/A) |
25.81 (68.49) |
165.36% | Details |
